Overview
Ryohiko Ozaki practices in Tokushima, Japan. Ozaki is rated as an Experienced expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Cerebellar Degeneration, and Paraneoplastic Cerebellar Degeneration.
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Interstitial PneumoniaOzaki isExperienced. Learn about Acute Interstitial Pneumonia.
- Cerebellar DegenerationOzaki isExperienced. Learn about Cerebellar Degeneration.
- Hypersensitivity PneumonitisOzaki isExperienced. Learn about Hypersensitivity Pneumonitis.
- Interstitial Lung DiseaseOzaki isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaOzaki isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerOzaki isExperienced. Learn about Lung Cancer.